Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Mustafa Erman,
Bivas Biswas,
Pongwut Danchaivijitr,
Lingwu Chen,
Yoke Fui Wong,
Tarek Hashem,
Chun Sen Lim,
Bulent Karabulut,
Hsiao-Jen Chung,
Chandrasekhar Chikatapu,
Sara Ingles,
Khemaies Slimane,
Ravindran Kanesvaran
Affiliations
Mustafa Erman
Medical Oncology, Hacettepe University
Bivas Biswas
Medical Oncology, Tata Medical Center
Pongwut Danchaivijitr
Medical Oncology, Siriraj Hospital, Mahidol University
Lingwu Chen
Medical Oncology, The First Affiliated Hospital of Sun Yat-sen, Guangzhou
Yoke Fui Wong
Radiotherapy and Oncology, National Cancer Institute
Tarek Hashem
Medical Oncology, Dr. Tarek Hashem’s Clinic
Chun Sen Lim
Clinical Oncology, Sultan Ismail Hospital
Bulent Karabulut
Medical Oncology, Ege University
Hsiao-Jen Chung
Department of Urology, Taipei Veterans General Hospital and Department of Urology, College of Medicine and Shu-Tien Urological Research Center, National Yang Ming Chiao Tung University
Chandrasekhar Chikatapu
Oncology, Novartis Healthcare Pvt. Ltd.
Sara Ingles
Oncology, Novartis Pharma AG
Khemaies Slimane
Oncology, Novartis Pharma SAS
Ravindran Kanesvaran
Division of Medical Oncology, National Cancer Centre Singapore
